Dynemicin c antitumour antibiotic

Details Dynemicin c antitumour antibiotic Dynemicin c antitumour antibiotic

C - Chemistry, Metallurgy

12

P

C12P 17/18 (2006.01) A61K 31/47 (2006.01) C07D 491/04 (2006.01) C07D 491/08 (2006.01) C12N 1/20 (2006.01)

Patent

CA 2054659

ABSTRACT The novel antitumor antibiotic designated herein as dynemicin C is produced by fermentation of Micromonospora chersina M956-1 mutant F1085 (ATCC-55077). Dynemicin C and its triacetate derivative possess antibacterial and antifun- gal activity and also inhibit the growth of mammalian tu- mors.

Affiliated with

Also associated with

Rating

Dynemicin c antitumour antibiotic does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dynemicin c antitumour antibiotic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dynemicin c antitumour antibiotic will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1898898